Sign up to save your podcasts
Or
Share FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen
FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.
View all episodes
By TheBrief.HealthFDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.